Despite hotter-than-expected CPI and PPI, markets rallied as confidence in the Fed's inflation-fighting credibility grew.

Anthropic (ANTHRO) nears a Nasdaq IPO as it targets a 2nd straight quarter of adjusted operating profit and surging revenue.

The FDA extended its review of Exelixis' zanzalintinib by three months, but no new clinical failure or safety signal was ...

Anthropic CEO Dario Amodei urges slowing AI development, proposing independent safety audits, industry standards, and global ...

There is an 87.3% probability that the FOMC will raise the current fed funds this week. How much of this is already in the ...

Operationally, Jeronimo Martins shows margin recovery and strong volume growth, especially in Biedronka and Ara, but EPS ...

Thematic ETFs allow investors to add deliberate exposure to structural change while diversifying beyond the increasingly ...

For most of its history, Zcash traded like a narrative-only privacy coin, falling roughly 99% from launch to September 2025.

VO ETF's modest income yield, mid-cap cyclicality, and premium valuation offer limited compensation. Read why VO is a Sell.

US municipal bonds posted positive returns in 2Q26 driven by strong fund flows and technical demand. Read the full analysis ...

Alexandria Real Estate's recent improvements in venture funding and leasing trends offer cautious optimism. Read why ARE ...

FTEC boasts a projected 28.84% next-year EPS growth rate and a 31.98x TTM P/E that's below its five-year average. Read why ...